Entacapone Market

Entacapone, a drug commonly used in the treatment of Parkinson's disease, together with levodopa and carbidopa, makes levodopa have a longer effect in the brain and is more levodopa than levodopa alone. And carbidopa treatment to reduce the signs and symptoms of Parkinson's disease for a longer period of time.
Entacapone Market contains market size and forecasts of Entacapone in global, including the following market information:
Global Entacapone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Entacapone Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Entacapone companies in 2021 (%)
The global Entacapone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity:98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Entacapone include Fermion, ACIC Pharmaceuticals, Apollo Pharmaceuticals, Jubilant Pharma, RXN Chemicals, Sudarshan Solvent Industries, Precise Chemipharma, Suven Life Sciences and HEC Pharm. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Entacapone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Entacapone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Entacapone Market Segment Percentages, by Type, 2021 (%)
Purity:98%
Purity:Above 98%
Global Entacapone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Entacapone Market Segment Percentages, by Application, 2021 (%)
Tablet Product
Capsule Product
Others
Global Entacapone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Entacapone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Entacapone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Entacapone revenues share in global market, 2021 (%)
Key companies Entacapone sales in global market, 2017-2022 (Estimated), (MT)
Key companies Entacapone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fermion
ACIC Pharmaceuticals
Apollo Pharmaceuticals
Jubilant Pharma
RXN Chemicals
Sudarshan Solvent Industries
Precise Chemipharma
Suven Life Sciences
HEC Pharm